PubMed · 16596748
Engineered bio-nanocapsules, the selective vector for drug delivery system.
Abstract
The bio-nanocapsule (BNC) is our concept of artificial hollow nanoparticles that have been designed and produced through biotechnological procedures. We proposed an empty virus-like particle, which consists of a recombinant L envelope protein of hepatitis B virus (HBV) and a lipid derived from the host cell, as an engineered BNC. Although this BNC was first developed as an immunogen of hepatitis B vaccine, the pre-S1 region in N-terminus of L envelope protein confers hepatocyte specific infectivity of HBV on the BNC. This recombinant BNC is now being developed as a novel platform of drug delivery system (DDS) vector for selective delivery.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Dongwei Yu, Takayuki Fukuda, Tuoya, Shun'ichi Kuroda, Katsuyuki Tanizawa, Akihiko Kondo, Masakazu Ueda, Tadanori Yamada, Hiroko Tada, Masaharu Seno. 2006. Engineered bio-nanocapsules, the selective vector for drug delivery system.. https://doi.org/10.1080/15216540500484368
Cite the original work for its findings. Save a collection to share your selection of sources.